From the start of 2019, Lisa Anson will serve as a director of the UK BioIndustry Association for a three-year term
() has confirmed its chief executive, Lisa Anson, has been elected to senior industry role.
From the start of 2019, she will serve as a director of the UK BioIndustry Association for a three-year term.
"I am delighted to be elected to join the BIA Board,” said Anson.
“I am passionate about the UK Biotech sector, as it is not only the focus for much of the exciting science in the UK, but it is also an important sector supporting the UK economy.
“Having previously been president of the Association of the British Pharmaceutical Industry (ABPI), I am personally excited at the prospect of working with the BIA to further the industry."
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Redx Pharma Plc named herein, including the promotion by the Company of Redx Pharma Plc in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HERE